Caption Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-109,500
| Closed | -$3.71M | – | 1970 |
|
|
2025
Q4 | $3.71M | Buy |
+109,500
| New | +$3.4M | 0.03% | 604 |
|
|
2025
Q1 | – | Sell |
-15,625
| Closed | -$198K | – | 1946 |
|
|
2024
Q4 | $198K | Buy |
+15,625
| New | +$198K | ﹤0.01% | 1279 |
|
|
2024
Q3 | – | Sell |
-88
| Closed | -$2.14K | – | 1539 |
|
|
2024
Q2 | $2.14K | Buy |
+88
| New | +$4.06K | ﹤0.01% | 1107 |
|
|
2022
Q3 | – | Sell |
-5,563
| Closed | -$812K | – | 1785 |
|
|
2022
Q2 | $812K | Buy |
+5,563
| New | +$741K | 0.01% | 948 |
|
|
2022
Q1 | – | Sell |
-4,038
| Closed | -$1.19M | – | 1854 |
|
|
2021
Q4 | $1.19M | Sell |
4,038
-525
| -12% | -$140K | 0.01% | 981 |
|
|
2021
Q3 | $1.13M | Sell |
4,563
-31,262
| -87% | -$8.26M | 0.01% | 983 |
|
|
2021
Q2 | $9.11M | Buy |
+35,825
| New | +$6.69M | 0.12% | 217 |
|
Caption Management's RAPT Position: Q4 2024 in Review
Caption Management sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 8,931 shares — an estimated $113K sold.
Caption Management first reported a position in RAPT in Q2 2021 and held it in 6 quarters. The position peaked at $13.4M in Q2 2021. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.
- Caption Management reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
- Caption Management sold 8,931 RAPT Therapeutics shares in Q4 2024, an estimated $113K.
- Caption Management first reported a position in RAPT Therapeutics in Q2 2021 and held it in 6 quarters.
- Caption Management's RAPT Therapeutics position peaked at $13.4M in Q2 2021.
- 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.
Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.